Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma [NA]

View source ↗

Summary

This clinical trial update reports on a study evaluating combination chemotherapy and Rituximab for patients with primary mediastinal large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Lymphoma | NA | Status: UNKNOWN